Mumbai-based pharmaceutical company Veer Health Care Ltd has outlined a bold revenue target of Rs. 40 crore for the financial year 2025–26, signaling an aggressive growth strategy rooted in portfolio expansion, strategic partnerships, and a deeper push into the ayurvedic and wellness space. Following strong momentum in recent quarters and an increasing demand for alternative therapies, the company is prioritizing scale, innovation, and distribution.